ORLANDO, Florida – Volvik USA, Inc., the innovative manufacturer of multilayer high-performance golf balls, increases its offerings in partnership with the Breast Cancer Research Foundation (BCRF) with a special edition of the all-new Vivid and Crystal Combi.
After receiving a strong response from the initial Vista3 BCRF edition, and leading up to Women’s Health Week May 12-18, the Volvik BCRF series now features three distinct performance models for golfers to show their support on the course.
Volvik USA will donate $1 to BCRF for each BCRF special edition dozen sold in 2024, with a minimum commitment of $20,000. BCRF is the largest private funder for breast cancer research worldwide and awarded $60.2 million in research grants in 2023-2024 to over 250 researchers.
“Adding Vivid and Crystal Combi to our BCRF partnership furthers our commitment to help raise awareness and provide support in the research needed to improve treatment options, and ultimately advance steps towards a cure,” said Pete Kinney, PGA, President of Volvik USA.
“The Volvik BCRF Collection includes a variety of golf balls for various skill levels; this will be a great aide for golf courses to create or add-on to existing programs as they conduct local fund-raising events around the country.”
Since its founding in 1993, researchers funded by BCRF have been behind every major breakthrough in breast cancer prevention, diagnosis, treatment, survivorship, and metastasis. With BCRF in the forefront of science and innovation funding worldwide, Volvik aligns and supports its mission to prevent and cure breast cancer.
For more information about BCRF, visit www.bcrf.org.
